Skip to content

Vaginal radiofrequency in improving urinary symptoms and sexual function

Determining the effectiveness of intravaginal radiofrequency in the improvement of urinary symptoms and sexual function in menopausal patients and comparison with control group

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180409039247N14
Enrollment
22
Registered
2026-05-27
Start date
2026-01-21
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vaginal atrophy. Menopausal and female climacteric states

Interventions

Intervention 1: Intervention group: Postmenopausal women in this group were treated with temperature-controlled vaginal radiofrequency waves. The treatment method involved the use of a radiofrequency

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 65 Years

Inclusion criteria

Inclusion criteria: Entering menopause Genitourinary syndrome in menopause women Vaginal pH higher than 5 No clinical history of malignancy or atypia Normal vaginal examination

Exclusion criteria

Exclusion criteria: History of hormone therapy for at least six months Pacemaker implantation History of implanting any metal device in the body History of hemophilia or other bleeding disorders Current diagnosis of vaginal infection

Design outcomes

Primary

MeasureTime frame
Dysuria. Timepoint: The effect of intravaginal radiofrequency on improving dysuria at pre-intervention, two weeks after the intervention, six months after the intervention, and twelve months after the intervention. Method of measurement: Urinary symptoms: including pain and burning after urination, occurrence of urinary or vaginal infections, using the UDI6 questionnare .;Sexual function. Timepoint: The effect of intravaginal radiofrequency on sexual function at the stages before the intervention, two weeks after the intervention, six months after the intervention, and twelve months after the intervention. Method of measurement: Assessing sexual function with the Women's Sexual Function Index (FSFI) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarjan Ghaemibidgoli

Tehran University of Medical Sciences

marjan_ghaemi@yahoo.com+98 21 8800 4858

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026